comparemela.com

Latest Breaking News On - Wuxi international life science innovation campus - Page 1 : comparemela.com

Chinese PE firm CICC ties up with UK s AstraZeneca for $338m healthcare fund

streetAsia s premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW Singapore Reporter/s In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digi

HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub

HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub HKSTP, AstraZeneca push Hong Kong as biomedical innovation hub 16 February 2021 | News Photo Credit: HKSTP AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation programme to support biomedical startups in their mission to develop integrated oncology solutions to accelerate innovation in oncology, foster local biomedical technologies and enhance Hong Kong’s status as a leading biomedical innovation hub. In the last decade, malignant cancerous tumours have been the number one cause of death among all diseases in Hong Kong. Today’s cancer treatment solutions, physical check-ups, diagnosis, treatment, follow-up and rehabilitation, are all interrelated. Improvements in either aspect of the patient journey will create huge opportunities to drive better treatment outcomes.

China Innovation Platform Wuxi iCampus Attracted Over 30 Global Firms in 2020

China Innovation Platform Wuxi iCampus Attracted Over 30 Global Firms in 2020 Yicai Global China Innovation Platform Wuxi iCampus Attracted Over 30 Global Firms in 2020 (Yicai Global) Feb. 9 Wuxi International Life Science Innovation Campus, also known as Wuxi iCampus, is an incubator that AstraZeneca co-built with the municipal government of Wuxi based on its global experience and resources in the healthcare sector. The life-sciences park aims to enable innovative enterprises to grow faster, and expand in the Chinese market and pursue their global journey. Through this inclusive platform, more innovative medical solutions can be incubated and more patients will benefit. More Ecosystem Than Medical Park

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.